Addressing Bias in Pharmaceutical Pipeline Forecasting

Richard Murgatroyd

Foresight: The International Journal of Applied Forecasting, 2025, issue 76, 40-46

Abstract: Due to some unique features of the pharmaceutical industry, epidemiology-based methods are commonly used in forecasting sales revenues for pipeline (i.e., new) products. Murgatroyd discusses the reasons for these potential manipulations and suggests what governance checks should be put in place to guard against them. Copyright International Institute of Forecasters, 2025

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://forecasters.org/foresight/bookstore/

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:for:ijafaa:y:2025:i:76:p:40-46

Access Statistics for this article

More articles in Foresight: The International Journal of Applied Forecasting from International Institute of Forecasters Contact information at EDIRC.
Bibliographic data for series maintained by Michael Gilliland ().